PickupJC, WilliamsG, JohnsP, et al.Clinical features of brittle diabetic patients unresponsive to optimised subcutaneous insulin therapy (continuous subcutaneous insulin infusion). Diabetes Care, 1983; 6: 279–84.
2.
CampbellF, MacdonaldAL, GelderC, ReynoldsC, HollandP, FeltblowerRG. Embedding CSII therapy in the routine management of diabetes in children: a clinical audit of this service in Leeds. Pract Diabetes Int, 2009; 26: 24–28.
3.
ChoudharyP, RamasamyS, BrackenridgeA, GreenL, GallenP, PenderS, AmielS, PickupJ. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. October, 2013 [Epub ahead of print] doi: 10.2337/dc13-0939.
4.
LyTT, NicholasJA, RetterathA, LimEM, DavisEA, JongYS. Reduction of severe hypoglycaemia with sensor-augmented insulin pump therapy and automated insulin suspension in patients with type 1 diabetes. Diabetes, 2013; 62 (Suppl 1): 58A.
5.
PickupJC. Glucose monitoring. In: Oxford Textbook of Endocrinology and Diabetes, edited by WassJAH, StewartPM. Oxford University Press, Oxford, 2011, pp. 1861–68.
6.
WeinstockRS, XingD, MaahsDM, MichelsA, RickelsMR, PetersAL, et al.Severe hypoglycaemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. [Epub ahead of print]; DOI: 10.1210/jc.2013-1589.
